Tvardi Therapeutics (TVRD) Assets: 2013-2017
Historic Assets for Tvardi Therapeutics (TVRD) over the last 4 years, with Sep 2017 value amounting to $108.0 million.
- Tvardi Therapeutics' Assets rose 34.80% to $108.0 million in Q3 2017 from the same period last year, while for Sep 2017 it was $108.0 million, marking a year-over-year increase of 34.80%. This contributed to the annual value of $63.8 million for FY2016, which is 42.44% down from last year.
- Latest data reveals that Tvardi Therapeutics reported Assets of $108.0 million as of Q3 2017, which was down 8.41% from $118.0 million recorded in Q2 2017.
- In the past 5 years, Tvardi Therapeutics' Assets ranged from a high of $118.0 million in Q2 2017 and a low of $18.1 million during Q4 2013.
- Moreover, its 3-year median value for Assets was $92.0 million (2016), whereas its average is $84.9 million.
- In the last 5 years, Tvardi Therapeutics' Assets skyrocketed by 209.32% in 2014 and then slumped by 57.56% in 2017.
- Quarterly analysis of 5 years shows Tvardi Therapeutics' Assets stood at $18.1 million in 2013, then skyrocketed by 209.32% to $55.9 million in 2014, then surged by 98.26% to $110.9 million in 2015, then tumbled by 42.44% to $63.8 million in 2016, then skyrocketed by 34.80% to $108.0 million in 2017.
- Its last three reported values are $108.0 million in Q3 2017, $118.0 million for Q2 2017, and $43.3 million during Q1 2017.